The incidence of HCC is 3–5-fold higher in male with respect to female patients [32] and this difference is even higher in HBV-related HCCs, which association with TP53 mutations has been widely demonstrated in the literature [3]. This evidence concerns the gene TP53 and hepatocellular carcinoma.